Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Embera NeuroTherapeutics to Present at the 10th Annual Biotech Showcase

Embera NeuroTherapeutics,Inc.
Posted on: 12 Dec 17

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine, and other addictions, today announced that Robert (Bob) Linke, the Company’s President and Chief Executive Officer, and Michael Detke, M.D., Ph.D., the Company’s Chief Medical Officer, will present at the 10th Annual Biotech Showcase on Monday, January 8, 2018 at 10:00 a.m. Pacific time. The conference is being held from January 8-10, 2018 at the Hilton San Francisco Union Square in San Francisco, California.

“Embera has a tremendous opportunity to further the development of EMB-001 into Phase 2 clinical trials in cocaine use disorder and tobacco use disorder. We are pleased with the opportunity to present at the Biotech Showcase to educate new audiences about our company and our lead candidate EMB-001 and its novel approach to addressing stress mediated diseases,” said Bob Linke.

About Embera NeuroTherapeutics

Embera NeuroTherapeutics, Inc. is a clinical-stage pharmaceutical company focused on stress modulation as an innovative way of treating a broad range of addictions and other diseases where there are significant public health impacts and a very limited range of effective therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions related to stress responses that drive craving and relapse associated with these disorders. Embera is advancing EMB-001 development programs in cocaine use disorder and smoking cessation.

View source version on

Business Wire

Last updated on: 12/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.